Fox Run Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-497
Closed -$205K 986
2024
Q2
$205K Buy
+497
New +$197K 0.04% 671
2024
Q1
Sell
-2,148
Closed -$658K 954
2023
Q4
$658K Buy
+2,148
New +$580K 0.17% 204
2023
Q3
Sell
-2,273
Closed -$546K 873
2023
Q2
$546K Buy
+2,273
New +$472K 0.15% 256

Other funds holding MEDP

Fox Run Management's MEDP Position: Q3 2024 in Review

Fox Run Management sold out of Medpace (MEDP) in Q3 2024, closing a stake of 497 shares — an estimated $205K sold.

Fox Run Management first reported a position in MEDP in Q2 2023 and held it in 3 quarters. The position peaked at $658K in Q4 2023. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

  • Fox Run Management reported no remaining Medpace position as of Q3 2024 after selling out during the quarter.
  • Fox Run Management sold 497 Medpace shares in Q3 2024, an estimated $205K.
  • Fox Run Management first reported a position in Medpace in Q2 2023 and held it in 3 quarters.
  • Fox Run Management's Medpace position peaked at $658K in Q4 2023.
  • 583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on Fox Run Management's 13F filing for Q3 2024, filed 12 Nov 2024.